BioBridges

biobridges.com

Are you a clinical development professional who recognizes career advancement by the ability to achieve satisfaction and growth through a focus on the work about which you are inspired? Are you a client who has programs that require additional support and could benefit from having access to a community of experienced professionals who can apply and share their functional expertise?

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

PFIZER CONTINUES RECALLS OF MENOPAUSE DRUG DUAVEE ON FAULTY PACKAGING CONCERNS

Fiercepharma | June 09, 2020

news image

Consumers are on edge as the COVID-19 pandemic casts doubts on the quality of drugs reaching shelves around the world. On U.S. shores, experts say those issues are warranted—and a wave of Pfizer recalls for menopause drug Duavee won't help build confidence. Pfizer voluntarily recalled two batches of Duavee––marketed as Duavive abroad––from U.K. shelves after identifying faulty packaging that may have reduced the drug's efficacy, the U.K.'s Medicines and ...

Read More

Business Insights

MITSUBISHI TANABE PHARMA AMERICA HIGHLIGHTS LATEST RESEARCH IN PARKINSON'S DISEASE AT EAN AND WPC 2023 CONGRESSES

prnewswire | July 06, 2023

news image

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of seven abstracts in Parkinson's disease (PD) at the 9th Congress of the European Academy of Neurology (EAN), which was held in Budapest, July 1-3, and the 6th World Parkinson Congress (WPC), being held in Barcelona, July 4-7. "Our presence at EAN and WPC this year underscores MTPA's dedication to investigating potential treatment options to tackle the current unmet needs and challenges ...

Read More

Business Insights

SANOFI GLOBAL HEALTH LAUNCHES NONPROFIT IMPACT® BRAND FOR 30 MEDICINES IN LOW-INCOME COUNTRIES

Sanofi | July 05, 2022

news image

Sanofi Global Health announces the launch of Impact®, a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries. The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover ...

Read More

UPADHYE CWIK LLP GUIDES ABOUT INNOVATIVE LEGAL PRACTICES ON PHARMACEUTICAL AND FDA ISSUES IN COVID-19 WORLD

Upadhye Cwik LLP | July 02, 2020

news image

The COVID-19 pandemic continues to turn the world upside down. And when upside down, the legal issues surrounding pharmaceuticals and the FDA become apparent. We identify a few areas that our law firm is working on for clients. Our patent work remains busy helping clients with rationalizing patent portfolios, conducting infringement-mapping exercises to find potential licensing revenues, and patent litigation to enforce patent rights. Interestingly we see some clients not cutting ...

Read More
news image

PFIZER CONTINUES RECALLS OF MENOPAUSE DRUG DUAVEE ON FAULTY PACKAGING CONCERNS

Fiercepharma | June 09, 2020

Consumers are on edge as the COVID-19 pandemic casts doubts on the quality of drugs reaching shelves around the world. On U.S. shores, experts say those issues are warranted—and a wave of Pfizer recalls for menopause drug Duavee won't help build confidence. Pfizer voluntarily recalled two batches of Duavee––marketed as Duavive abroad––from U.K. shelves after identifying faulty packaging that may have reduced the drug's efficacy, the U.K.'s Medicines and ...

Read More
news image

Business Insights

MITSUBISHI TANABE PHARMA AMERICA HIGHLIGHTS LATEST RESEARCH IN PARKINSON'S DISEASE AT EAN AND WPC 2023 CONGRESSES

prnewswire | July 06, 2023

Mitsubishi Tanabe Pharma America, Inc. (MTPA) today announced the presentation of seven abstracts in Parkinson's disease (PD) at the 9th Congress of the European Academy of Neurology (EAN), which was held in Budapest, July 1-3, and the 6th World Parkinson Congress (WPC), being held in Barcelona, July 4-7. "Our presence at EAN and WPC this year underscores MTPA's dedication to investigating potential treatment options to tackle the current unmet needs and challenges ...

Read More
news image

Business Insights

SANOFI GLOBAL HEALTH LAUNCHES NONPROFIT IMPACT® BRAND FOR 30 MEDICINES IN LOW-INCOME COUNTRIES

Sanofi | July 05, 2022

Sanofi Global Health announces the launch of Impact®, a new brand of standard of care medicines produced by Sanofi dedicated for nonprofit distribution to at-risk populations in the world’s most impoverished countries. The Impact® brand, which includes insulin, glibenclamide and oxaliplatin amonst others, will enable the secure distribution of 30 Sanofi medicines in 40 lower-income countries. Considered essential by the World Health Organization, the medicines cover ...

Read More
news image

UPADHYE CWIK LLP GUIDES ABOUT INNOVATIVE LEGAL PRACTICES ON PHARMACEUTICAL AND FDA ISSUES IN COVID-19 WORLD

Upadhye Cwik LLP | July 02, 2020

The COVID-19 pandemic continues to turn the world upside down. And when upside down, the legal issues surrounding pharmaceuticals and the FDA become apparent. We identify a few areas that our law firm is working on for clients. Our patent work remains busy helping clients with rationalizing patent portfolios, conducting infringement-mapping exercises to find potential licensing revenues, and patent litigation to enforce patent rights. Interestingly we see some clients not cutting ...

Read More

Resources

Events

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us